139 related articles for article (PubMed ID: 37815746)
1. Serum sex hormones correlate with pathological features of papillary thyroid cancer.
Xu FZ; Zheng LL; Chen KH; Wang R; Yi DD; Jiang CY; Liu ZJ; Shi XB; Sang JF
Endocrine; 2024 Apr; 84(1):148-154. PubMed ID: 37815746
[TBL] [Abstract][Full Text] [Related]
2. A protective factor against lymph node metastasis of papillary thyroid cancer: Female gender.
Shi P; Yang D; Liu Y; Zhao Z; Song J; Shi H; Wu Y; Jing S
Auris Nasus Larynx; 2023 Jun; 50(3):440-449. PubMed ID: 36253315
[TBL] [Abstract][Full Text] [Related]
3. Thyroid stimulating hormone levels and BRAFV600E mutation contribute to pathophysiology of papillary thyroid carcinoma: Relation to outcomes?
Sulaieva O; Chernenko O; Chereshneva Y; Tsomartova D; Larin O
Pathophysiology; 2019 Jun; 26(2):129-135. PubMed ID: 31097263
[TBL] [Abstract][Full Text] [Related]
4. Relationship between subgroups of central and lateral lymph node metastasis in clinically node-negative papillary thyroid carcinoma.
Zhou J; Li DX; Gao H; Su XL
World J Clin Cases; 2022 Apr; 10(12):3709-3719. PubMed ID: 35647144
[TBL] [Abstract][Full Text] [Related]
5. The binary presence or absence of lymph node metastasis or extrathyroidal extension is not associated with survival in papillary thyroid cancers: Implications for staging systems.
Zhang HS; Lee EK; Jung YS; Nam BH; Park B
Cancer Epidemiol; 2019 Dec; 63():101589. PubMed ID: 31494519
[TBL] [Abstract][Full Text] [Related]
6. Prediction model of cervical lymph node metastasis based on clinicopathological characteristics of papillary thyroid carcinoma: a dual-center retrospective study.
Liu W; Zhang D; Jiang H; Peng J; Xu F; Shu H; Su Z; Yi T; Lv Y
Front Endocrinol (Lausanne); 2023; 14():1233929. PubMed ID: 37766691
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of sex hormones and expression of their receptors in thyroid tissue in female patients with various types of thyroid neoplasms.
Liu J; Chen G; Meng XY; Liu ZH; Dong S
Pathol Res Pract; 2014 Dec; 210(12):830-5. PubMed ID: 25305147
[TBL] [Abstract][Full Text] [Related]
8. Serum TSH levels are associated with postoperative recurrence and lymph node metastasis of papillary thyroid carcinoma.
Xiang Y; Xu Y; Bhandari A; Sindan N; Hirachan S; Yang Q; Guo G; Shen Y
Am J Transl Res; 2021; 13(6):6108-6116. PubMed ID: 34306349
[TBL] [Abstract][Full Text] [Related]
9. [Effect of the steroid sex hormones on the LH and FSH responses to LHRH in the normal subject].
Lemarchand-Béraud T; Reymond M; Rappoport G; Magrini G; Gomez J
Pathol Biol (Paris); 1975 Dec; 23(10):917-22. PubMed ID: 772543
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological and ultrasound features as risk stratification predictors of clinical and pathological nodal status in papillary thyroid carcinoma: a study of 748 patients.
Zhang C; Li B; Zhang L; Chen F; Zhang Y; Cheng W
BMC Cancer; 2022 Apr; 22(1):354. PubMed ID: 35365120
[TBL] [Abstract][Full Text] [Related]
11. [Correlations between hormone levels and psychiatric symptoms as well as cognitive function in drug-free first-episode schizophrenics].
Yuan XX; Zhu QY; Liang HB; Hei GR; Li X; Pang LJ; Li HH; Li H; Song XQ
Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(27):2155-60. PubMed ID: 27464540
[TBL] [Abstract][Full Text] [Related]
12. Low serum 25 hydroxyvitamin D is associated with poor clinicopathologic characteristics in female patients with papillary thyroid cancer.
Kim JR; Kim BH; Kim SM; Oh MY; Kim WJ; Jeon YK; Kim SS; Lee BJ; Kim YK; Kim IJ
Thyroid; 2014 Nov; 24(11):1618-24. PubMed ID: 25133449
[TBL] [Abstract][Full Text] [Related]
13. Sex hormones influence survival of patients with metastatic urothelial carcinoma undergoing immune checkpoint therapy.
Lindner AK; Lackner F; Tymoszuk P; Barth DA; Seeber A; Kocher F; Toth B; Hochleitner M; Pichler M; Pichler R
Biol Sex Differ; 2023 Jun; 14(1):38. PubMed ID: 37277835
[TBL] [Abstract][Full Text] [Related]
14. Clinical and prognosis value of the number of metastatic lymph nodes in patients with papillary thyroid carcinoma.
Zhan L; Feng HF; Yu XZ; Li LR; Song JL; Tu Y; Yuan JP; Chen C; Sun SR
BMC Surg; 2022 Jun; 22(1):235. PubMed ID: 35725426
[TBL] [Abstract][Full Text] [Related]
15. [Clinical analysis of lymphocytic thyroiditis coexistent with papillary thyroid carcinoma].
Wang SX; She ZQ; An CM; Zhang XW; Li ZJ; Tang PZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 51(4):277-81. PubMed ID: 27095720
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of ultrasonic features and microscopic extrathyroidal extension in the recurrence of PTC.
Yang J; Zhao C; Niu X; Wu S; Li X; Li P; Ning C
Eur J Radiol; 2022 Dec; 157():110518. PubMed ID: 36327854
[TBL] [Abstract][Full Text] [Related]
17. Differential expression patterns and clinical significance of estrogen receptor-α and β in papillary thyroid carcinoma.
Huang Y; Dong W; Li J; Zhang H; Shan Z; Teng W
BMC Cancer; 2014 May; 14():383. PubMed ID: 24884830
[TBL] [Abstract][Full Text] [Related]
18. Influence Factors for Lymph Node Metastasis in Papillary Thyroid Carcinoma: Hashimoto's Thyroiditis Has a Weak Effect on Central or Lateral Lymph Node Metastasis.
Zhou L; Chen G; Sheng L; Liu N; Zhang B; Zeng Q; Chen B
Cancer Manag Res; 2021; 13():3953-3961. PubMed ID: 34017198
[TBL] [Abstract][Full Text] [Related]
19. Cervical Lymph Node Metastases of Papillary Thyroid Carcinoma, in the Central and Lateral Compartments, in Children and Adolescents: Predictive Factors.
Spinelli C; Tognetti F; Strambi S; Morganti R; Massimino M; Collini P
World J Surg; 2018 Aug; 42(8):2444-2453. PubMed ID: 29383423
[TBL] [Abstract][Full Text] [Related]
20. Papillary thyroid microcarcinomas that metastasize to lymph nodes.
Dirikoc A; Tam AA; Ince N; Ozdemir D; Topaloglu O; Alkan A; Yazgan AK; Ersoy R; Cakir B
Am J Otolaryngol; 2021; 42(5):103023. PubMed ID: 33838358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
